Vaginal dryness

53% of menopausal women have vaginal dryness1 (atrophic vaginitis), but only 20% of sufferers ask for help2.

The symptoms of vaginal dryness include pain during sexual intercourse (dyspareunia), vaginal itching, discharge, inflammation or urinary problems. They may be alleviated by hormone replacement therapy but this is not always a preferred or recommended treatment, particularly if other medical conditions are present.

Hyalofemme is an extremely effective treatment for vaginal dryness, as good as 0.1% oestrogen. 88% of women who were using Hyalofemme said it improved their symptoms, while 96% would recommend it to a friend3. Hyalofemme has a unique mode of action, and delivers moisture inside the cells, plumping them up and helping the tissue to recover.

What is atrophic vaginitis?

Most women first notice the issue when they experience painful sex. This happens because the vagina is not moist and lubricated. Some women may also find that the vagina’s tissue is more delicate and irritable. Sex without adequate lubrication can lead to microlesions, microscopic wounds in the vaginal tissue, which exacerbate pain and can lead to vaginal infections.

Some women may notice that they are producing a white or yellow discharge. This may just be part of the menopausal process, but if the discharge has an unpleasant odour, it is likely to be caused by an underlying infection.

An itching vagina can also be a sign of atrophic vaginitis. Some women may find that because of the increased sensitivity in the genital area, it can quite often feel itchy. Unfortunately, this can lead to a cycle of itching and scratching, because the action of scratching intensifies the sensitivity and makes it more prone to itching.

If you experience symptoms such as increased discharge, itching, burning or odour, please consult your GP.

1. The REVIVE (REal Women’s VIews of Treatment Options for Menopausal Vaginal ChangEs) survey in Europe. Nappi et al, Maturitas, Sep 2016
2. Bachmann GA, Nevadunsky NS Diagnosis and treatment of atrophic vaginitis. Am Fam Physician 2000
3. HyaloGYN Marketing and Efficacy, 2011, data on file at Fidia Pharma USA inc.

Purple Orchid Pharma Ltd
82c East Hill, Colchester, Essex CO1 2QW, United Kingdom
Company Registered No: 07870913
info@purpleorchidpharma.com

Copyright @ Purple Orchid Pharma Ltd